Viewing Study NCT01482104


Ignite Creation Date: 2025-12-24 @ 9:22 PM
Ignite Modification Date: 2026-02-02 @ 2:15 AM
Study NCT ID: NCT01482104
Status: COMPLETED
Last Update Posted: 2017-10-27
First Post: 2011-11-17
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: New Versus Approved Methyl-aminolevulinate Photodynamic Therapy (MAL-PDT) Regime in Basal Cell Carcinoma (BCC)
Sponsor: Norwegian University of Science and Technology
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Skin Neoplasms View
None Carcinoma, Basal Cell View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Photochemotherapy View
None methyl 5-aminolevulinate View